13G Filing: Venor Capital Management and Bioscrip Inc. (BIOS)

(i)         Venor Capital Management LP (“Venor Capital Management”), a Delaware limited partnership, as investment manager to four private investment funds (the “Private Funds”), and investment adviser to an investment account (collectively with the Private Funds, the “Accounts”), with respect to the Shares reported in this Schedule 13G held by the Accounts.

(ii)        Venor Capital Management GP LLC (“Venor Capital GP”), a Delaware limited liability company, as general partner of Venor Capital Management with respect to the Shares as reported in this Schedule 13G held by the Accounts.

(iii)       Venor Special Situations Fund II LP (“Venor Special Situations”), a Delaware limited partnership and one of the Accounts, with respect to certain of the Shares as reported in this Schedule 13G.

(iv)       Venor Special Situations GP LLC (“Venor Special Situations GP”), a Delaware limited liability company, as general partner of Venor Special Situations with respect to certain of the Shares as reported in this Schedule 13G.

(v)        Jeffrey A. Bersh, as a managing member of Venor Capital GP and Venor Special Situations GP and Co-Chief Investment Officer of Venor Capital Management, with respect to the Shares reported in this Schedule 13G held by the Accounts.

(vi)       Michael J. Wartell, as a managing member of Venor Capital GP and Venor Special Situations GP and Co-Chief Investment Officer of Venor Capital Management, with respect to the Shares reported in this Schedule 13G held by the Accounts.

The citizenship of Venor Capital Management, Venor Capital GP, Venor Special Situations and Venor Special Situations GP is set forth above.  Jeffrey A. Bersh and Michael J. Wartell are United States citizens.

The address of the principal business office of each of the Reporting Persons is 7 Times Square, Suite 4303, New York, NY 10036.